Long term dietary indole-3-carbinol inhibits diethylnitrosamine-initiated hepatocarcinogenesis in the infant mouse model

Cancer Letters

Volumn 118, Issue 1, 1997, Pages 87-94

  Oganesian, Aram ^a   Hendricks, Jerry D ^a   Williams, David E ^a  

^a OREGON STATE UNIVERSITY   (United States)

Author keywords

3,4,5,3',4',5' hexachlorobiphenyl (HCB); Aryl hydrocarbon (Ah); Diethylnitrosamine (DEN); Indole 3 carbinol (I3C)

Indexed keywords

3 INDOLEMETHANOL; DIETHYLNITROSAMINE; HEXACHLOROBIPHENYL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIET SUPPLEMENTATION; LIVER CARCINOGENESIS; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; AGING; ANIMALS; ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CARCINOGENS; DIETHYLNITROSAMINE; FEMALE; FOOD, FORTIFIED; HUMANS; INDOLES; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; TIME FACTORS;

ANIMALIA;

EID: 0030876480     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(97)00235-8     Document Type: Article

References (49)

1. D.J. Kim, K.K. Lee, B.S. Han, B. Ahn, J.H. Bae, J.J. Jang, Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione S-transferase placental form-positive liver cell foci in Sprague-Dawley rats, Jpn. J. Cancer Res. 86 (1994) 578-583.
2. M.N. Preobrazhenskaya, V.M. Bukhman, A.M. Korolev, S.A. Efimov, Ascorbigen and other indole-derived compounds from Brassica vegetables and their analogs as anticarcinogenic and immunomodulating agents, Pharmacol. Ther. 60 (1993) 301-313.
3. R.H. Dashwood, A.T. Fong, J.D. Hendricks, G.S. Bailey, Tumor dose-response studies with aflatoxin B1 and the ambivalent modulator indole-3-carbinol: inhibitory versus promotional potency, in: Y. Kuroda, D.M. Shankei, M.D. Waters (Eds.), Antimutagenesis and Anticarcinogenesis Mechanisms, Plenum, New York, 1990, pp. 361-365.
4. T. Tanaka, Y. Mory, Y. Morishita, A. Hara, T. Ohno, T. Kojima, H. Mori, Inhibitory effect of sinigrin and indole-3-carbinol on diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats, Carcinogenesis 11 (1990) 1403-1406.
5. T. Kojima, T. Tanaka, H. Mori, Chemoprevention of spontaneous endometrial cancer in female Donrye rats by dietary indole-3-carbinol, Cancer Res. 54 (1994) 1446-1449.
6. G.D. Stoner, G. Adam-Rodwell, M.A. Morse, Lung tumors in strain A mice: application for studies in cancer chemoprevention, J. Cell. Biochem. Suppl. 17F (1993) 95-103.
7. F.L. Chung, M.A. Morse, K.I. Eklind, Y. Xu, Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis by compounds derived from cruciferous vegetables and green tea, Ann. N. Y. Acad. Sci. 686 (1993) 186-201.
8. M.A. Morse, S.D. LaGreca, S.G. Amin, F.L. Chung, Effects of indole-3-carbinol on lung tumorigenesis and DNA methylation induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and on the metabolism and disposition of NNK in A/J mice, Cancer Res. 50 (1990) 2613-2617.
9. K. El-Bayoumy, P. Upadhyaya, D. Desai, S. Amiri, D. Hoffmann, E.L. Wynder, Effects of 1,4-phenylenebis (methylene) selenocyanate, phenethylisothiocyanate, indole-3-carbinol, and d-limonene individually and in combination on the tumorigenicity of the tobacco-specific nitrosamine 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mouse lung, Anticancer Res. 16 (1996) 2709-2712.
10. C.J. Grubbs, V.E. Steele, T. Casebolt, M.M. Juliana, I. Eto, L.M. Whitaker, K.H. Dragnev, G.J. Kelloff, R.L. Lubet, Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol, Anticancer Res. 15 (1995) 709-716.
11. T. Tanaka, T. Kojima, Y. Morishita, H. Mori, Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis, Jpn. J. Cancer Res. 83 (1992) 835-842.
12. D. Guo, H.A.J. Schut, C.D. Davis, E.G. Snyderwine, G.S. Bailey, R.H. Dashwood, Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6-phenylimidazo[4,5-6]pyridine (PhIP)-induced DNA adducts and colonie aberrant crypts in the F344 rat, Carcinogenesis 16 (1995) 2931-2937.
13. G.S. Bailey, R.H. Dashwood, A.T. Fong, D.E. Williams, R.A. Scanlan, J.D. Hendricks, Modulation of mycotoxin and nitrosamine carcinogenesis by indole-3-carbinol: quantitative analysis of inhibition versus promotion, in: I.K. O'Neill, J. Chen, H. Bartsch, (Eds.), Relevance to Human Cancer of N-Nitroso Compounds, International Agency for Research on Cancer, Lyon, 1991, pp. 275-280.
14. H.L. Bradlow, D.W. Sepkovic, N.T. Telang, M.P. Osborne, Indole-3-carbinol. A novel approach to breast cancer prevention, Ann. N. Y. Acad. Sci. 768 (1995) 180-200.
15. T. Niwa, G. Swaneck, H.L. Bradlow, Alterations in estradiol metabolism in MFC-7 cells induced by treatment with indole3-carbinol and related compounds, Steroids 59 (1994) 523-527.
16. H.L. Bradlow, J.J. Michnovicz, M. Halper, D.G. Miller, G.Y. Wong, M.P. Osborne, Long-term responses of women to indole-3-carbinol or a high fiber diet, Cancer Epidemiol. Biomarkers Prev. 3 (1994) 591-595.
17. A. Suto, H.L. Bradlow, G.Y. Wong, M.P. Osborne, N.T. Telang, Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cells, Steroids 57 (1992) 262-268.
18. H.L. Bradlow, J. Michnovicz, N.T. Telang, M.P. Osborne, Effects of indole-3-carbinol on estradiol metabolism and spontaneous mammary tumors in mice, Carcinogenesis 12 (1991) 1571-1574.
19. W.S. Baldwin, G.A. LeBlanc, The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450 mediated steroid hydroxylase activities in mice, Chem.-Biol. Interact. 83 (1992) 155-169.
20. D.W. Sepkovic, H.L. Bradlow, J. Michnovicz, S. Murtezani, I. Levy, M.P. Osborne, Catechol estrogen production in rat microsomes after treatment with indole-3-carbinol, ascorbigen, or β-naphthoflavone: a comparison of stable isotope dilution gas chromatography-mass spectrometry and radiometric methods, Steroids 59 (1994) 318-323.
21. 3H]methyltrienolone. Inhibition of steroid binding activity by the anticarcinogen indole-3-carbinol, Biochem. J. 288 (1992) 361-367.
22. M.B. Arnao, J. Sanchez-Bravo, M. Acosta, Indole-3-carbinol as a scavenger of free radicals, Biochem. Mol. Biol. Int. 34 (1996) 1125-1134.
23. J.G. Christensen, G.A. LeBlanc, Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol, Cancer Res. 56 (1996) 574-581.
24. D.M. Stresser, D.E. Williams, L.I. McLellan, T.M. Harris, G.S. Bailey, Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo, Drug Metab. Dispos. 22 (1994) 392-399.
25. D.M. Stresser, G.S. Bailey, D.E. Williams, Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat, Drug Metab. Dispos. 22 (1994) 383-391.
26. H.M. Wolterboer, E.C. van-der-Linden, C.A. De-Kruif, J. Noordhoek, B.J. Blaauboer, P.J. van-Bladeren, H.E. Falke, Effects of indole-3-carbinol on biotransformation enzymes in the rat: in vivo changes in liver and small intestinal mucosa in comparison with primary hepatocyte cultures, Food Chem. Toxicol. 30 (1992) 589-599.
27. J.Y. Park, L.F. Bjeldanes, Organ-selective induction of cytochrome P-450-dependent activities by indole-3-carbinol-derived products: influence on covalent binding of benzo[a]-pyrene to hepatic and pulmonary DNA in the rat, Chem.-Biol. Interact. 83 (1992) 235-247.
28. W.S. Baldwin, G.A. LeBlanc, The anti-carcinogenic plant compound indole-3-carbinol differentially modulates P450-mediated steroid hydroxylase activities in mice, Chem.-Biol. Interact. 83 (1992) 155-169.
29. H. Liu, M. Wormke, S.H. Safe, L.F. Bjeldanes, Indolo[3,2-B]carbazole: a dietary-derived factor that exhibits both anti-estrogenic and estrogenic activity, J. Natl. Cancer Inst. 86 (1994) 1758-1765.
30. R.H. Dashwood, A.T. Fong, D.N. Arbogast, L.F. Bjeldanes, J.D. Hendricks, G.S. Bailey, Anticarcinogenic activity of indole-3-carbinol acid products: ultrasensitive bioassay by trout embryo microinjection, Cancer Res. 54 (1994) 1617-1619.
31. K.R. Grose, L.F. Bjeldanes, Oligomerization of indole-3-carbinol in aqueous acid, Chem. Res. Toxicol. 5 (1992) 188-193.
32. C.A. De-Kruif, J.W. Marsman, J.C. Venecamp, H.E. Falke, J. Noordhoek, B.J. Blaauboer, H.M. Wortelboer, Structure elucidation of acid reaction products of indole-3-carbinol: detection in vivo and enzyme induction in vitro, Chem.-Biol. Interact. 80 (1991) 303-315.
33. P.H. Jellinck, P.G. Forkert, D.S. Riddick, A.B. Okey, J.J. Michnovicz, H.L. Bradlow, Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylation, Biochem. Pharmacol. 45 (1993) 1129-1136.
34. L.F. Bjeldanes, J.Y. Kim, K.R. Grose, J.C. Bartholomew, C.A. Bradfield, Aromatic hydrocarbon responsiveness; receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin, Proc. Natl. Acad. Sci. USA 88 (1991) 9543-9547.
35. Y.H. Chen, J. Riby, P. Srivastava, J. Bartholomew, M. Denison, L. Bjeldanes, Regulation of CYP1A1 by indolo[3,2-b]carbazole in murine hepatoma cells, J. Biol. Chem. 210 (1985) 22548-22555.
36. M.I. Kleman, L. Poellinger, J.-A. Gustafsson, Regulation of human dioxin receptor function by indolocarbazoles, receptor ligands of dietary origin, J. Biol. Chem. 269 (1994) 5137-5144.
37. D.M. Stresser, D.E. Williams, D.A. Griffin, G.S. Bailey, Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats, Drug Metab. Dispos. 23 (1995) 965-975.
38. X. Ge, S. Yannis, G. Rennert, N. Gruener, F.A. Fares, 3,3′-Diindolylmethane induces apoptosis in human cancer cells, Biochem. Biophys. Res. Commun. 228 (1996) 153-158.
39. D.M. Stresser, L.F. Bjeldanes, G.S. Bailey, D.E. Williams, The anticarcinogen 3,3′-diindolylmethane is an inhibitor of cytochrome P450, J. Biochem. Toxicol. 10 (1995) 191-201.
40. 1-DNA adduction and mutagenesis by I3C acid condensation products, Food Chem. Toxicol. 33 (1995) 851-857.
41. C. Sasagawa, T. Matsushima, Mutagen formation on nitrite treatment of indole compounds derived from indoleglucosinolate, Mutat. Res. 250 (1991) 169-174.
42. J.D. Yager, R. Yager, Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats, Cancer Res. 40 (1980) 3680-3685.
43. I.R. Wanless, A. Medline, Role of estrogens as promoters of hepatic neoplasia, Lab. Invest. 46 (1982) 313-319.
44. A.M. Standeven, D.C. Wolf, T.L. Goldsworthy, Interactive effects of unleaded gasoline and estrogen on liver rumor promotion in female B6C3F1 mice, Cancer Res. 54 (1994) 1198-1204.
45. R.H. Dashwood, A.T. Fong, D.E. Williams, J.D. Hendricks, G.S. Bailey, Promotion of aflatoxin B1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose, duration, and intermittent exposure on indole-3-carbinol promotional potency, Cancer Res. 51 (1994) 2362-2365.
46. AVMA, The 1993 report of AVMA panel on euthanasia, J. Am. Vet. Med. Assoc. 202 (1993) 229-249.
47. T.M. Poole, N.R. Drinkwater, Strain dependent effects of sex hormones on hepatocarcinogenesis in mice, Carcinogenesis 17 (1996) 191-196.
48. G.H. Lee, K. Nomura, T. Kitagawa, Comparative study of diethylnitrosamine-initiated two-stage carcinogenesis in C3H, C57BL and BALB mice promoted by various hepatopromoters, Carcinogenesis 10 (1989) 2227-2230.
49. J.D. Yager, H.A. Campbell, D.S. Longnecker, B.D. Roebuck, M.C. Benoit, Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol, Cancer Res. 44 (1984) 3862-3869.